Michael A Vogelbaum

14PUBLICATIONS
114CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersRadiation therapyMajor global burdens of diseaseMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Oct 08, 2026
Targeting hypoxia-driven histone lactylation in myeloid cells synergizes with CD137 agonism to expand effector-like exhausted CD8+ T cells in glioblastoma.

|Aug 12, 2026
Prognostic and Predictive Effect of Age in Molecularly Defined Lower-Grade Gliomas.

|May 27, 2026
Long-Term Analysis of NRG Oncology RTOG 0539: A Phase II Trial of Observation for Low-Risk Meningioma and Radiotherapy for Intermediate- and High-Risk Meningioma.

|Feb 27, 2025
Functional Reprogramming of Neutrophils within the Brain Tumor Microenvironment by Hypoxia-Driven Histone Lactylation.

Alessio Ugolini, Alessandra De Leo, Xiaoqing Yu

|Jun 04, 2024
Multidisciplinary Management of Isocitrate Dehydrogenase-Mutated Gliomas in a Contemporary Molecularly Defined Era.

Rupesh Kotecha, David Schiff, Arnab Chakravarti

|May 21, 2024
Consensus review on strategies to improve delivery across the blood-brain barrier including focused ultrasound.

Keaton Piper, Jay I Kumar, Joseph Domino

Pageof 3

Frequent Collaborators

4 joint publications

Paul D Brown

4 joint publications

Minesh P Mehta

3 joint publications

David Schiff

3 joint publications

Andrew B Lassman